Nuveen Asset Management, LLC Keros Therapeutics, Inc. Transaction History

Nuveen Asset Management, LLC

  • $340 Billion
  • Q4 2024

A detailed history of Nuveen Asset Management, LLC transactions in Keros Therapeutics, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 79,485 shares of KROS stock, worth $909,308. This represents 0.0% of its overall portfolio holdings.

Number of Shares
79,485
Previous 261,348 69.59%
Holding current value
$909,308
Previous $15.2 Million 91.71%
% of portfolio
0.0%
Previous 0.0%

Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
SELL
$15.64 - $70.0 $2.84 Million - $12.7 Million
-181,863 Reduced 69.59%
79,485 $1.26 Million
Q3 2024

Nov 14, 2024
BUY
$41.68 - $58.07 $6.4 Million - $8.92 Million
153,568 Added 142.48%
261,348 $15.2 Million
Q2 2024

Aug 09, 2024
BUY
$44.58 - $66.89 $291,597 - $437,527
6,541 Added 6.46%
107,780 $4.93 Million
Q1 2024

May 13, 2024
BUY
$41.26 - $70.48 $1.06 Million - $1.81 Million
25,643 Added 33.92%
101,239 $6.7 Million
Q4 2023

Feb 14, 2024
BUY
$27.12 - $41.05 $124,155 - $187,926
4,578 Added 6.45%
75,596 $3.01 Million
Q3 2023

Nov 14, 2023
BUY
$31.57 - $43.02 $611,163 - $832,824
19,359 Added 37.47%
71,018 $2.26 Million
Q2 2023

Aug 14, 2023
SELL
$37.26 - $51.01 $577,902 - $791,165
-15,510 Reduced 23.09%
51,659 $2.08 Million
Q1 2023

May 15, 2023
BUY
$41.44 - $59.32 $75,835 - $108,555
1,830 Added 2.8%
67,169 $2.87 Million
Q4 2022

Feb 14, 2023
BUY
$39.45 - $51.77 $25,484 - $33,443
646 Added 1.0%
65,339 $3.14 Million
Q3 2022

Nov 14, 2022
BUY
$27.8 - $40.12 $48,733 - $70,330
1,753 Added 2.79%
64,693 $2.43 Million
Q2 2022

Aug 15, 2022
BUY
$26.03 - $67.04 $63,643 - $163,912
2,445 Added 4.04%
62,940 $1.74 Million
Q1 2022

May 16, 2022
SELL
$42.12 - $59.36 $125,601 - $177,011
-2,982 Reduced 4.7%
60,495 $3.08 Million
Q4 2021

Feb 14, 2022
SELL
$36.95 - $62.89 $170,893 - $290,866
-4,625 Reduced 6.79%
63,477 $2.97 Million
Q3 2021

Nov 12, 2021
SELL
$29.27 - $43.71 $1.39 Million - $2.07 Million
-47,363 Reduced 41.02%
68,102 $2.09 Million
Q2 2021

Aug 16, 2021
SELL
$42.4 - $70.11 $374,052 - $618,510
-8,822 Reduced 7.1%
115,465 $4.9 Million
Q1 2021

May 17, 2021
BUY
$54.0 - $75.28 $1.58 Million - $2.2 Million
29,275 Added 30.81%
124,287 $7.65 Million
Q4 2020

Feb 16, 2021
BUY
$36.0 - $82.74 $2.45 Million - $5.62 Million
67,928 Added 250.8%
95,012 $6.7 Million
Q3 2020

Nov 16, 2020
BUY
$27.04 - $62.21 $3,082 - $7,091
114 Added 0.42%
27,084 $1.05 Million
Q2 2020

Aug 14, 2020
BUY
$20.08 - $40.39 $541,557 - $1.09 Million
26,970 New
26,970 $1.01 Million

Others Institutions Holding KROS

# of Institutions
177
Shares Held
31.1M
Call Options Held
646K
Put Options Held
670K
View Full List

About Keros Therapeutics, Inc.

KROS Quotes by TradingView
  • Ticker KROS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 25,757,000
  • Market Cap $295M
  • Description
  • Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...
More about KROS
Track This Portfolio

Track Nuveen Asset Management, LLC Portfolio

Follow Nuveen Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email